Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor necrosis factor receptor superfamily member 3 (TNFRSF3), also known as lymphotoxin beta receptor (LTβR), is a cell surface transmembrane protein that belongs to the tumor necrosis factor receptor superfamily. It primarily functions as a receptor for the heterotrimeric lymphotoxin complex containing lymphotoxin-alpha and lymphotoxin-beta, as well as for the ligand LIGHT/TNFSF14. LTβR is essential for the development and organization of secondary lymphoid organs and plays a role in apoptosis, cytokine release, and hepatic diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor Necrosis Factor Receptor Superfamily Member 3 (TNFRSF3).